Argosy Overseas Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 06-12-2024
- Paid Up Capital ₹ 4.40 M
as on 06-12-2024
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 228.94%
(FY 2023)
- Ebitda 2145.21%
(FY 2023)
- Net Worth 0.22%
(FY 2023)
- Total Assets 1.34%
(FY 2023)
About Argosy Overseas
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.40 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Srivastava, Sunita Srivastava, and Sunil Srivastava serve as directors at the Company.
- CIN/LLPIN
U51109DL1989PTC036784
- Company No.
036784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationNa, Delhi
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Argosy Overseas?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Srivastava  | Director | 05-Dec-1999 | Current |
| Sunita Srivastava | Director | 05-Dec-1999 | Current |
Sunil Srivastava  | Director | 19-Sep-2020 | Current |
Financial Performance of Argosy Overseas.
Argosy Overseas Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 228.94% increase in profit. The company's net worth moved up by a moderate rise of 0.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Argosy Overseas?
Unlock access to Argosy Overseas's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chem Genes India Private LimitedActive 22 years 5 monthsSuresh Srivastava and Sunita Srivastava are mutual person
Magadh Avadh Chemical Industries Private LimitedActive 32 years 4 monthsSuresh Srivastava is a mutual person
- Milan Shyam Bio Sciences Private LimitedActive 5 years 2 months
Suresh Srivastava and Sunita Srivastava are mutual person
- Ess Cee Biotech (India) Private LimitedActive 38 years 7 months
Suresh Srivastava and Sunita Srivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Argosy Overseas?
Unlock and access historical data on people associated with Argosy Overseas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Argosy Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Argosy Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
